Pharmaceutical Society of Australia

What Pharmaceutical Society of Australia does

The Pharmaceutical Society of Australia (PSA) is the national peak body representing all 41,000+ pharmacists across Australia, operating as a nonprofit professional membership association headquartered in Canberra with state and territory branch committees in ACT, NSW, QLD, SA/NT, TAS, VIC, and WA. The organisation delivers accredited education, training, and professional development through the myPSA portal and learning management system, offering products including the PSA Intern Training Program (11255NAT Graduate Certificate, $2,295), the College Intern Training Program ($1,950), the 11404NAT Graduate Certificate in Pharmacist Prescribing ($11,495–$12,495), and a CPD catalogue. Its proprietary Australian Pharmaceutical Formulary (APF/APF Digital) is mandated by the Pharmacy Board of Australia for pharmacist practice and is distributed through the PSA bookshop as a digital subscription and printed edition.

PSA's business model combines recurring membership subscriptions (Professional Plus, Advantage, Essential, and Graduate tiers) with revenue from accredited training programs, APF publication sales, national and state conferences (including PSA26 at ICC Sydney), and grant/sponsorship income from industry partners such as MIMs, GSK, Pfizer, Camurus, and Care Pharmaceuticals. The organisation publishes the Australian Pharmacist Journal and operates the Palliative Care Community of Practice alongside member-only services such as the Pharmacist Advice Line, scholarship programs (Faye McMillan Conference Grant, Hugh and Mary Darragh Postgraduate Scholarship), and a 2026 Code of Ethics framework. PSA engages in government advocacy through the #UncapCare campaign and annual budget submissions, and runs specialised programs including the Deadly Pharmacists cultural safety training suite (co-designed with NACCHO), the ASPIRE Palliative Care Foundation Training Program, and the Vaccination Ambassador and Harm Reduction Champion initiatives.

Name

Pharmaceutical Society of Australia

Legal name

Pharmaceutical Society of Australia Ltd.

Website

https://psa.org.au

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

101–250 employees

Short description

The Pharmaceutical Society of Australia is the national peak body representing all 41,000+ Australian pharmacists, delivering accredited training, the mandated APF clinical reference, advocacy, and professional development services across all practice settings.

Ownership category

akta.pro rank

Product category

Pharmacy Professional Membership and Education

NAICS

Professional, Scientific, and Technical Services (541)

akta.pro primary industry

Schools of Pharmacy (EDAHAGAE)

akta.pro secondary industry

Pharmacy Benefit Management (PBM) & Formulary Management IT (HLACAKAD)

Keywords

• Pharmacy professional association
• Pharmacist continuing education
• Accredited training programs
• Clinical reference publications
• Pharmacy advocacy services

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Membership Subscriptions: PSA generates revenue through professional membership subscriptions at multiple tiers (Professional Plus, Advantage, Essential, and Graduate membership). Membership provides access to CPD, resources, advocacy, and member-only benefits including the Pharmacist-to-Pharmacist advice line.
2. Training and Education Programs: Revenue from accredited training programs including Intern Training Programs ($2,295 and $1,950), Graduate Certificate in Pharmacist Prescribing ($11,495-$12,495), and Pharmacist Prescribing Scope of Practice Training Program. Programs offered with flexible payment options and membership discounts.
3. Publications and Formularies: Sales of Australian Pharmaceutical Formulary (APF Digital subscriptions - single user and site licences) and APF26 printed edition through the PSA bookshop. APF is mandated by Pharmacy Board of Australia for pharmacist practice.
4. Conference and Event Revenue: National annual conference PSA26 and state-based events generate revenue through registrations. Includes community of practice memberships and sponsored event programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

The Pharmaceutical Society of Australia is a national professional membership association that delivers accredited education and training, clinical reference publications, advocacy, and practice support to Australia's 41,000+ pharmacists. Its principal products are the Australian Pharmaceutical Formulary (APF/APF Digital), the Intern Training Programs (PSA ITP and College ITP), the Graduate Certificate in Pharmacist Prescribing, and a CPD catalogue, all delivered via the myPSA digital portal and a national branch network. PSA also publishes the Code of Ethics, Professional Practice Standards, and the Australian Pharmacist Journal, and provides member services such as the Pharmacist Advice Line.

Product overview

The Pharmaceutical Society of Australia offers a comprehensive portfolio of professional development products and services for pharmacists across all practice settings. The core offerings include accredited Intern Training Programs (PSA ITP and College ITP) for pharmacy graduates, the Pharmacist Prescribing Scope of Practice Training Program and 11404NAT Graduate Certificate in Pharmacist Prescribing for expanded scope practice, and the Australian Pharmaceutical Formulary (APF/APF Digital) as the mandated clinical reference. Supporting programs include the Deadly Pharmacists cultural safety training suite, ASPIRE Palliative Care Foundation Training, CPD catalogue, and various advocacy programs including the Vaccination Ambassador Program and Harm Reduction Champion. Additional offerings include professional scholarships (Faye McMillan Conference Grant, Hugh and Mary Darragh Postgraduate Scholarship), networking communities (Palliative Care Community of Practice), and professional standards (Code of Ethics for Pharmacists). The organization also publishes the Australian Pharmacist Journal.

Differentiator

Problem solved

Functional benefit

Products and services

• PSA Intern Training Program Accredited intern training program for pharmacy graduates seeking national recognition. On completion, graduates receive 11255NAT Graduate Certificate in Applied Pharmacy Practice. Fee: $2,295 (including GST) with flexible 6-monthly installment payment options.
• College Intern Training Program Intern training program designed for dynamic pharmacy workplaces, integrated with on-the-job experience. Provides Certificate of Completion. Fee: $1,950 (including GST) with 6 monthly installments of $325.00.
• Pharmacist Prescribing Scope of Practice Training Program Comprehensive training combining the Prescribing Training Program (APC-accredited, aligned with NPS Prescribing Competencies Framework) and the Clinical Practice Training Program. Includes online modules, face-to-face workshops, OSCE assessments, and prescriber mentor integration. Self-paced with 18-month expected duration and jurisdiction-specific modules.
• 11404NAT Graduate Certificate in Pharmacist Prescribing Nationally recognised qualification providing pharmacists with advanced skills in patient consultation, clinical decision-making, health coaching, medication management, and interprofessional collaboration. Five core units including NAT11404001 Apply clinical knowledge and skills for safe prescribing (APC accredited). Fee: $11,495-$12,495 depending on membership tier.
• Australian Pharmaceutical Formulary (APF/APF Digital) Essential clinical reference handbook mandated by the Pharmacy Board of Australia. APF Digital provides monthly updates including treatment guidelines, compounding information, and 30+ minor ailment guidelines, with exclusive digital-only chapters on evidence-based medicine, biosimilar medicines, opioid substitution therapy, and more. Available as digital subscription (Single User or Site Licence) or printed APF26 edition.
• CPD Catalogue Continuing Professional Development resources and accreditation services for pharmacists, including access to extensive CPD library and CPD planning tool as part of PSA membership.
• Deadly Pharmacists Program Cultural safety training suite for pharmacists working with Aboriginal and Torres Strait Islander peoples. Includes seven existing modules plus new community pharmacy-specific module. Co-designed with NACCHO. Funded by Australian Government under Medical Research Future Fund and NSW Ministry of Health.
• ASPIRE Palliative Care Foundation Training Program Foundation training program for pharmacists in palliative care, developed in collaboration with Palliative Care Australia, Ageing Australia, and caring@home.
• Palliative Care Community of Practice Community of practice connecting pharmacists involved in or interested in palliative care. Led by Chair Penny Tuffin FPS. Supported by Department of Health, Disability and Ageing through QUDTP Commonwealth Funding.
• Code of Ethics for Pharmacists Professional ethics framework for all pharmacists and pharmacy students registered with the Pharmacy Board of Australia. Redesigned in 2026 with four domains: Care, Integrity, Competency, and Collaboration. Addresses expanding pharmacist roles including prescribing, vaccination, and digital health.
• Australian Pharmacist Journal Peer-reviewed professional journal covering pharmacy practice, clinical updates, and industry news. Published by PSA.
• Pharmacist Advice Line Member-exclusive professional advice service providing practice support and guidance to pharmacists.
• Your medicines, your pharmacist Consumer Guide Consumer-facing guide developed in partnership with Autism SA and working group members with lived experience of autism to support inclusive pharmacy practice. Supported by a grant from the Office for Autism, Government of South Australia.

Quantifiable outcome

• PSA represents 41,000 pharmacists across all Australian practice settings
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• NACCHO (National Aboriginal Community Controlled Health Organisation)coreStrategic or Co-development PartnerPSA collaborates with NACCHO on Indigenous health initiatives including the IPAC trial, Deadly Pharmacists Foundation Training Course, and co-design of culturally safe care programs. NACCHO is the national peak body for Aboriginal Community Controlled Health Services. The partnership focuses on improving health outcomes for Aboriginal and Torres Strait Islander peoples through pharmacist integration in ACCHSs and culturally safe healthcare delivery.
• MIMsminorStrategic or Co-development PartnerMIMs is a partner in PSA's Intern Training Program, providing the MIMs Intern of the Year award sponsorship. The partnership supports excellence in intern pharmacy training and professional development recognition.
• GSK and PfizerminorGTM or Marketing PartnerGSK and Pfizer provide support for the PSA Vaccination Ambassador Program, recognising pharmacist leaders advancing vaccination services in communities and nationally. The program provides a platform for pharmacist immunisers to influence policy and support ongoing vaccination advocacy efforts.
• CamurusminorGTM or Marketing PartnerCamurus provides grant support for PSA's first Harm Reduction Champion initiative and sponsors the Faye McMillan Conference Grant. The partnership aims to elevate pharmacist leadership in harm reduction and support First Nations pharmacist participation in the profession.
• Care Pharmaceuticals and HydralyteminorGTM or Marketing PartnerCare Pharmaceuticals and Hydralyte sponsor the PSA Faye McMillan Conference Grant for the third consecutive year (2026), supporting Aboriginal and/or Torres Strait Islander pharmacists, interns, and pharmacy students to attend PSA's national conference.
• Palliative Care Australia, Ageing Australia, and caring@homecoreStrategic or Co-development PartnerPSA launched its Palliative Care Community of Practice in collaboration with Palliative Care Australia, Ageing Australia, and caring@home during National Palliative Care Week May 2026. The consortium is supported by the Department of Health, Disability and Ageing through QUDTP Palliative Care Consortium Project. The COP aims to connect, engage, and empower pharmacists involved in palliative care across all practice settings.
• Autism SA and Office for Autism (South Australia)minorStrategic or Co-development PartnerPSA developed the 'Your medicines, your pharmacist' consumer guide in partnership with Autism SA, expert pharmacists, and working group members with lived experience of autism. Supported by a grant from the Office for Autism, Government of South Australia. A further grant through Autism Works in the Community Grants program funds development of a Pharmacist Audit Tool and Checklist for autism-inclusive practice.
• Australian Pharmacy Council (APC)coreTechnology or IntegrationAPC provides accreditation for PSA's Intern Training Program and Prescribing Training Program. PSA's programs are aligned with the APC Performance Outcomes Framework and National Competency Standards Framework for Pharmacists in Australia. APC accreditation ensures programs meet national quality standards for pharmacist registration requirements.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Royal Pharmaceutical Society: The Royal Pharmaceutical Society (RPS) is the UK professional membership body for pharmacists, providing professional development, advocacy, and standards-setting functions. It is the most directly comparable international peer to PSA in scope, mission, and membership-association model.
• American Pharmacists Association: APhA is the largest US national professional association of pharmacists, providing advocacy, education, training, and credentialing. It is structurally analogous to PSA as a membership body delivering CPD, training programs, and policy advocacy for pharmacists across all practice settings.
• Canadian Pharmacists Association: CPhA is the national professional body representing Canadian pharmacists, offering advocacy, continuing education, and publications. It closely mirrors PSA's role as the unified national voice for pharmacists across practice settings.
• Pharmaceutical Society of New Zealand: PSNZ is the professional association for New Zealand pharmacists, providing education, training, and advocacy in a similarly sized, English-speaking Commonwealth jurisdiction. It is highly comparable to PSA in scale, regulatory environment, and scope of practice.
• Society of Hospital Pharmacists of Australia: SHPA represents Australian hospital pharmacists specifically, providing specialty training, advocacy, and CPD. It competes with PSA for members within the hospital pharmacist segment and is the closest Australia-only direct peer despite its narrower specialty focus.
• Pharmacy Guild of Australia: The Pharmacy Guild represents Australian community pharmacy owners rather than individual pharmacists, but competes with PSA for advocacy influence, training delivery, and member engagement across the Australian pharmacy sector under successive Community Pharmacy Agreements.
• Royal Dutch Pharmacists Association (KNMP): KNMP is the professional association for pharmacists in the Netherlands, providing advocacy, professional standards, and training. It is structurally analogous to PSA as a national peak body with regulatory influence over pharmacy practice and education.
• Pharmaceutical Society of Ireland: PSI is the pharmacy regulator and professional support body for pharmacists in Ireland, combining regulatory and professional-development functions. It is comparable to PSA in operating a single national pharmacy body serving all pharmacist practice settings.

Broad incumbents

• International Pharmaceutical Federation: FIP is the global federation of national pharmacy associations, of which PSA is a member. While broader in geographic and organisational scope, FIP overlaps with PSA on international pharmacy standards, education frameworks, and advocacy positioning.

Regional players

• National Pharmacy Association (UK): The NPA represents UK community pharmacy owners and is comparable to Pharmacy Guild of Australia in scope. It serves as a regional peer representing a parallel owner-pharmacist constituency in a different but closely related Commonwealth healthcare system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/PSA_national
• Facebookfacebook.com/PharmaceuticalSociety
• LinkedInlinkedin.com/company/pharmaceutical-society-of-australia

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceutical Society of Australia